You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gastroesophageal cancer

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer, GastroEsophageal Cancer Trial in Aurora, Colorado Springs, Highlands Ranch (Pembrolizumab, Olaparib,

Recruiting
  • Gastric Cancer
  • GastroEsophageal Cancer
  • Aurora, Colorado
  • +2 more
Jan 4, 2023

Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer, Locally Advanced Unresectable Gastric

Available
  • Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma Cancer
  • +3 more
  • Morristown, New Jersey
    AMG Hematology/Oncology
Sep 15, 2023

Pancreatic Cancer, GastroEsophageal Cancer, Rectal Cancer Trial in Boston (Supportive Oncology Care at Home, Usual Care)

Recruiting
  • Pancreatic Cancer
  • +3 more
  • Supportive Oncology Care at Home
  • Usual Care
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 18, 2022

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (Capecitabine, oxaliplatin, Disitamab Vedotin)

Not yet recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Beijing, Beijing, China
  • +10 more
Nov 23, 2023

Gastro Esophageal Reflux Trial in Nijmegen (No intervention)

Active, not recruiting
  • Gastro Esophageal Reflux
  • No intervention
  • Nijmegen, Gelderland, Netherlands
    Radboudumc
Jan 16, 2023

Esophageal Adenocarcinoma Trial in Clermont-Ferrand (Adipose tissue biopsies)

Not yet recruiting
  • Esophageal Adenocarcinoma
  • Adipose tissue biopsies
  • Clermont-Ferrand, France
    CHU de Clermont-Ferrand
Jul 19, 2023

Adenocarcinoma, Stomach Tumor, Gastroesophageal-junction Cancer Trial in Shanghai (radiation, biological, drug, procedure)

Recruiting
  • Adenocarcinoma
  • +8 more
  • Radiotherapy targeted to the primary lesion
  • +7 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 7, 2023

Gastric Adenocarcinoma, GastroEsophageal Cancer Trial in Orange, Sacramento (TAS-102, Irinotecan)

Active, not recruiting
  • Gastric Adenocarcinoma
  • GastroEsophageal Cancer
  • Orange, California
  • +1 more
Apr 4, 2022

Gastric Cancer Trial (S-1, Oxaliplatin, Cadonilimab)

Not yet recruiting
  • Gastric Cancer
  • S-1, Oxaliplatin, Cadonilimab
  • (no location specified)
Jul 10, 2023

2D and 3D Primary Cell Cultures From Gastric and

Not yet recruiting
  • Gastric and Gastroesophageal Junction Cancer
    • Berlin, Germany
      Department of Anesthesiology and Operative Intensive Care Medici
    Sep 13, 2022

    Gastric or Gastroesophageal Junction Cancer Trial in Beijing (SHR-1701?CAPOX/FOLFOX, Placebo?CAPOX/FOLFOX)

    Recruiting
    • Gastric or Gastroesophageal Junction Cancer
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Dec 14, 2021

    Gastroesophageal Junction Adenocarcinoma Trial in Shijiazhuang (Oxaliplatin; Capecitabine, Oxaliplatin; Capecitabine; concurrent

    Completed
    • Gastroesophageal Junction Adenocarcinoma
    • Oxaliplatin; Capecitabine
    • Oxaliplatin; Capecitabine; concurrent radiotherapy
    • Shijiazhuang, Hebei, China
      Department of General Surgery
    Feb 4, 2022

    HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma Trial (SHR-A1811, Ramucirumab / Paclitaxel/

    Not yet recruiting
    • HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
    • SHR-A1811
    • Ramucirumab / Paclitaxel/ Docetaxel/ Irinotecan
    • (no location specified)
    Nov 6, 2023

    Advanced Malignant Solid Tumor, Clinical Stage III Gastroesophageal Junction Adenocarcinoma, Clinical Stage IV Gastroesophageal

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +28 more
    • Trifluridine and Tipiracil Hydrochloride
    • Talazoparib Tosylate
    • Buffalo, New York
      Roswell Park Cancer Institute
    Mar 2, 2022

    Gastric Cancer, Gastroesophageal-junction Cancer Trial (Tcrx T cell)

    Not yet recruiting
    • Gastric Cancer
    • Gastroesophageal-junction Cancer
    • Tcrx T cell
    • (no location specified)
    Jul 21, 2022

    Gastric / Gastroesophageal Junction Adenocarcinoma Trial in Shanghai (envafolimab and lenvatinib combined with

    Enrolling by invitation
    • Gastric / Gastroesophageal Junction Adenocarcinoma
    • envafolimab and lenvatinib combined with paclitaxel-albumin
    • Shanghai, Shanghai, China
      Fudan University Cancer Hospital
    Sep 3, 2023

    Gastric or Gastroesophageal Junction Adenocarcinoma Trial in Nanjing (neoadjuvant chemo-hypofractionated radiotherapy plus PD-1

    Active, not recruiting
    • Gastric or Gastroesophageal Junction Adenocarcinoma
    • neoadjuvant chemo-hypofractionated radiotherapy plus PD-1 antibody (Tislelizumab)
    • Nanjing, Jiangsu, China
      Jiangsu Cancer Hospital
    Jul 4, 2023

    Gastroesophageal Cancer, Adenocarcinoma Trial in United States (Pembrolizumab, Abemaciclib)

    Active, not recruiting
    • Gastroesophageal Cancer
    • Adenocarcinoma
    • Indianapolis, Indiana
    • +3 more
    Feb 16, 2022

    Esophageal Tumor, Adenocarcinoma of the Gastroesophageal Junction, GastroEsophageal Cancer Trial in United States (DKN-01)

    Available
    • Esophageal Neoplasm
    • +9 more
    • Birmingham, Alabama
    • +3 more
    Aug 24, 2022

    Gastric Cancer, Gastroesophageal Junction (GEJ) Cancer Trial (T-Dxd(Trastuzmab deruxtecan), Ramucirumab)

    Not yet recruiting
    • Gastric Cancer
    • Gastroesophageal Junction (GEJ) Cancer
    • T-Dxd(Trastuzmab deruxtecan), Ramucirumab
    • (no location specified)
    Jun 7, 2023

    Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Duarte, South

    Withdrawn
    • Esophageal Squamous Cell Carcinoma
    • +2 more
    • Duarte, California
    • +2 more
    Feb 21, 2022

    Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial

    Not yet recruiting
    • Advanced Esophageal Adenocarcinoma
    • +14 more
    • (no location specified)
    Jan 3, 2023

    Advanced Colorectal Carcinoma, Advanced Digestive System Carcinoma, Advanced Gastric Carcinoma Trial in United States

    Recruiting
    • Advanced Colorectal Carcinoma
    • +42 more
    • Duarte, California
    • +9 more
    Jan 21, 2023

    Gastric Adenocarcinoma, Adenocarcinoma of Gastroesophageal Junction Trial in Guangzhou (Docetaxel for injection (Albumin-bound),

    Recruiting
    • Gastric Adenocarcinoma
    • Adenocarcinoma of Gastroesophageal Junction
    • Docetaxel for injection (Albumin-bound)
    • Taxotere
    • Guangzhou, China
      Ethics Committee of Sun-Yat-Sen University Cancer Center
    Jan 27, 2023

    Gastric Cancer, GastroEsophageal Cancer Trial in Wuhan (Albumin-bound Paclitaxel Plus SHR-1210 (PD-1 inhibitor), Albumin-bound

    Active, not recruiting
    • Gastric Cancer
    • GastroEsophageal Cancer
    • Albumin-bound Paclitaxel Plus SHR-1210 (PD-1 inhibitor)
    • Albumin-bound Paclitaxel
    • Wuhan, Hubei, China
      Tongji hospital of Tongji Medical College, Huazhong University o
    Jan 21, 2023